GENE THERAPY WITH P19ARF AND INTERFERON-BETA SENSITIZES CELLS TO PD-1 CHECKPOINT BLOCKADE AND ENHANCES ANTITUMOR IMMUNE RESPONSES IN RESISTANT MOUSE MODELS
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | |
dc.contributor.author | DOMINGUES, Ana | |
dc.contributor.author | TESSAROLLO, Nayara | |
dc.contributor.author | STRAUSS, Bryan | |
dc.date.accessioned | 2023-07-18T14:17:50Z | |
dc.date.available | 2023-07-18T14:17:50Z | |
dc.date.issued | 2022 | |
dc.description.index | MEDLINE | |
dc.description.index | PubMed | |
dc.description.index | WoS | |
dc.description.sponsorship | Sao Paulo Research Foundation (FAPESP) | |
dc.identifier.citation | JOURNAL FOR IMMUNOTHERAPY OF CANCER, v.10, suppl.2, p.A479-A479, 2022 | |
dc.identifier.doi | 10.1136/jitc-2022-SITC2022.0459 | |
dc.identifier.eissn | 2051-1426 | |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/54465 | |
dc.language.iso | eng | |
dc.publisher | BMJ PUBLISHING GROUP | eng |
dc.relation.ispartof | Journal for Immunotherapy of Cancer | |
dc.rights | restrictedAccess | eng |
dc.rights.holder | Copyright BMJ PUBLISHING GROUP | eng |
dc.subject.wos | Oncology | eng |
dc.subject.wos | Immunology | eng |
dc.title | GENE THERAPY WITH P19ARF AND INTERFERON-BETA SENSITIZES CELLS TO PD-1 CHECKPOINT BLOCKADE AND ENHANCES ANTITUMOR IMMUNE RESPONSES IN RESISTANT MOUSE MODELS | eng |
dc.type | conferenceObject | eng |
dc.type.category | meeting abstract | eng |
dc.type.version | publishedVersion | eng |
dspace.entity.type | Publication | |
hcfmusp.author.external | TESSAROLLO, Nayara:Inst Nacl Canc, Rio De Janeiro, Brazil | |
hcfmusp.contributor.author-fmusphc | ANA CAROLINA MARTINS DOMINGUES | |
hcfmusp.contributor.author-fmusphc | BRYAN ERIC STRAUSS | |
hcfmusp.description.beginpage | A479 | |
hcfmusp.description.endpage | A479 | |
hcfmusp.description.issue | suppl 2 | |
hcfmusp.description.volume | 10 | |
hcfmusp.origem | WOS | |
hcfmusp.origem.wos | WOS:000919423400444 | |
hcfmusp.publisher.city | LONDON | eng |
hcfmusp.publisher.country | ENGLAND | eng |
hcfmusp.relation.reference | Barrueto L, 2020, TRANSL ONCOL, V13, DOI 10.1016/j.tranon.2019.12.010 | eng |
hcfmusp.relation.reference | Chada S, 2021, CANCER GENE THER, DOI 10.1038/s41417-021-00369-7 | eng |
hcfmusp.relation.reference | Hunger A, 2017, CELL DEATH DISCOV, V3, DOI 10.1038/cddiscovery.2017.17 | eng |
hcfmusp.relation.reference | Wenthe J, 2022, MOL THER-ONCOLYTICS, V24, P429, DOI 10.1016/j.omto.2022.01.003 | eng |
relation.isAuthorOfPublication | d81b4af3-1063-42dd-bc2e-1bbe803eb93d | |
relation.isAuthorOfPublication | 2dcf8225-1aa3-4b94-869a-6769561b3515 | |
relation.isAuthorOfPublication.latestForDiscovery | d81b4af3-1063-42dd-bc2e-1bbe803eb93d |